Stock Markets July 16, 2026 08:12 AM

SharonAI Jumps After $1.32 Billion Cloud Contract; New Zealand AI Factory Deployment Planned

Shares climb 10% as the Australian Neocloud firm signs a five-year cloud computing services deal and outlines GPU and capacity targets

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
SHAZ

SharonAI Holdings Inc. (NASDAQ: SHAZ) saw its stock rise 10% following disclosure of a $1.32 billion, five-year cloud computing services agreement with a global Artificial Intelligence Lab. The deal will see SharonAI deploy cloud solutions across data center infrastructure in New Zealand, with revenue from the contract expected to begin in the first and second quarters of 2027. The company reported total AI Factory capacity of 132MW, with 116MW already contracted, and plans to install more than 62,000 NVIDIA GPUs by mid-2027.

SharonAI Jumps After $1.32 Billion Cloud Contract; New Zealand AI Factory Deployment Planned
SHAZ
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • SharonAI signed a five-year cloud computing services agreement worth $1.32 billion with a global Artificial Intelligence Lab.
  • The contract involves deploying cloud computing solutions across data center infrastructure in New Zealand, with revenue expected in Q1 and Q2 of 2027.
  • The company reports 132MW of total AI Factory capacity, 116MW of which is already contracted, and expects to deploy over 62,000 NVIDIA GPUs by mid-2027.

SharonAI Holdings Inc. (NASDAQ: SHAZ) experienced a 10% gain in its share price on Thursday after announcing a five-year cloud services contract valued at $1.32 billion with a global Artificial Intelligence Lab.

The agreement calls for SharonAI to supply cloud computing solutions across data center infrastructure located in New Zealand. According to the company, revenues tied to the contract are anticipated to begin in the first and second quarters of 2027.

SharonAI described itself as an Australian Neocloud provider and reported that its total AI Factory capacity currently stands at 132MW. Of that capacity, 116MW is already under contract to end customers, the company said.

In addition to capacity figures, SharonAI provided a deployment target for accelerator hardware: the company expects to deploy more than 62,000 NVIDIA GPUs by mid-2027.

Commenting on the New Zealand project, James Manning, Co-founder and CEO of SharonAI, said: "We are excited to be deploying our first AI Factory in New Zealand." He added, "The established data center infrastructure and future growth potential in country provide Sharon AI with a strong foundation for future expansion."

Manning also stated that SharonAI continues to observe strong demand from a range of customer types, explicitly including enterprise, government, hyperscale, AI native and research customers across Asia-Pacific and Rest of World.


Below are the key factual elements disclosed by the company: the five-year, $1.32 billion contract; New Zealand as the deployment location; revenue commencement expected in Q1 and Q2 of 2027; AI Factory capacity of 132MW with 116MW contracted; and an expected deployment of more than 62,000 NVIDIA GPUs by mid-2027.

The company statement and executive comments provide the basis for the stock move announced on Thursday. No additional timelines or contingencies beyond the revenue commencement window in 2027 were disclosed in the company statements provided with the announcement.

Risks

  • Timing uncertainty - revenue from the agreement is expected to begin in the first and second quarters of 2027, creating a multi-quarter lead time before contract revenues commence.
  • Execution risk tied to hardware deployment - the company’s plans depend on deploying more than 62,000 NVIDIA GPUs by mid-2027.
  • Dependency on New Zealand infrastructure - the contract centers on data center deployments in New Zealand, which the company cited as the foundation for expansion but did not further detail.

More from Stock Markets

Stifel Flags Ciena and Viavi as Standouts in Applied Technologies Equipment and Test Jul 16, 2026 Merck Secures FDA Clearance for Lipfendra, First Oral PCSK9 Cholesterol Therapy Jul 16, 2026 GE Aerospace Says GEnx Shipments Have Risen, Has Months of Engines at Boeing Charleston Site Jul 16, 2026 Benchmark Starts Coverage on Synopsys and Cadence with Buy Ratings, Citing AI-Led EDA Tailwinds Jul 16, 2026 ManpowerGroup Shares Jump After Q2 Beat, UBS Raises Target as Shorts Cover Jul 16, 2026